Levana Sani is the co-founder and CEO of NalaGenetics. In this episode, Levana shares how her background in biochemistry and her MBA from Harvard Business School helped shape her understanding of the business side of science. She explains the four main problems NalaGenetics aims to solve in the field of genetic testing and the challenges they faced in the early stages. Additionally, she highlights the differences in commercialisation in Singapore and Indonesia, and the current challenges faced with the adoption and application of pharmacogenomics in clinics. Host: Jessie WongEditors: Jessie Wong, John Joson Ng The show notes and transcripts for the episode can be found onnucleatesingapore.substack.com. For feedback or recommendations on who we should talk to next, please reach out to Joson Ng via [email protected]. 01:00 - Introduction05:09 - Early beginnings of NalaGenetics12:11 - Product development and market expansion17:10 - Technology and democratization of genetics24:15 - Future outlook